Benign prostatic hyperplasia: Cost and effectiveness of three alternative surgical treatment methods used in a Turkish hospital

被引：1

作者：

Agirbas I. ^{[1
]}

Tatar M. ^{[2
]}

Kisa A. ^{[3
]}

机构：

[1] Department of Health Administration, School of Health Education, Ankara University, Kecioren, Ankara

[2] School of Health Administration, Hacettepe University, Ankara

[3] Department of Health Administration, Baskent University, School of Health Sciences, 06530, Ankara

来源：

Journal of Medical Systems | 2005年 / 29卷 / 5期

关键词：

Benign prostatic hyperplasia; Cost effectiveness; Laser prostatectomy; Open prostatectomy; TURP;

D O I：

10.1007/s10916-005-6105-5

中图分类号：

学科分类号：

摘要：

The purpose of this study was to compare three alternative surgical therapies for Benign prostatic hyperplasia (BPH) in terms of their cost and effectiveness in a general hospital setting in Turkey. BPH is an important potential burden on health care resources in developing countries like Turkey, not only because of the increasing incidence of the disease, but also because of the differences in cost and effectiveness that exist among the various available treatment technologies. In this study, three alternative surgical treatments for BPH, namely open prostatectomy, transurethral resection of the prostate (TURP), and laser prostatectomy were compared in terms of their cost and effectiveness. Effectiveness was measured through the use of the International Prostate Symptom Score (IPSS) before the operation and at 3 months after. Laser prostatectomy was found to be the most costly and least effective way of treating BPH. This conclusion was valid both in terms of cost per prostate symptom score and cost per improvement of quality of life index. This study shows how a rough estimate can be made of the potential burdens that alternative treatment methods would impose on a country's health budget. © 2005 Springer Science+Business Media, Inc.

引用

页码：487 / 492

页数：5

共 10 条

[1]

Ozkara H., Alici B., Akkus E., Ataus S., Hattat H., TUR-P ve Transvezikal Prostatektomi Ameliyatlarinin Seksüel Fonksiyon Üzerine Etkisi, Cerrahpaşa Tip Dergisi, 29, 3

[2]

Zlotta A.R., Schulman C.C., BPH and sexuality, Eur. Urol., 36, 1 SUPPL., pp. 107-112, (1999)

[3]

Tatar C., Benign prostat hiperplazisinde endoskopik cerrahi ile tedavi ve lazer prostatektominin yeri, Saǧlik Dergisi, 66, (1997)

[4]

Drummond M.F., McGuire A.J., Black N.A., Petticrew M., McPherson C.K., Economic burden of treated benign prostatic hyperplasia in the United Kingdom, Br. J. Urol., 71, 3, pp. 290-296, (1993)

[5]

Kortt M.A., Bootman J.L., The Oxford laser prostate trial: Economic issues surrounding contact laser prostatectomy, Clin. Ther., 18, 6, pp. 1227-1241, (1996)

[6]

Lowe F.C., McDaniel R.L., Chmiel J.J., Hillman A.L., Economic modeling to assess the costs of treatment with finasteride terazosin and transurethral resection of prostate for men with moderate to severe symptoms of benign prostatic hyperplasia, Urology, 46, 4, pp. 477-483, (1995)

[7]

Blomqvist P., Ekborn A., Carlsson P., Ahlstrand C., Johansson J.E., Benign prostatic hyperplasia in Sweden 1987 to 1994: Changing patterns of costs, Urology, 50, 2, pp. 214-220, (1997)

[8]

Eri L.M., Tveter K.J., Treatment of benign prostatic hyperplasia: A pharmacoeconomic perspective, Drugs Aging, 10, 2, pp. 107-118, (1997)

[9]

D'Ancona F.C., Franciska E.A., Wityes W.P., Welling L., Debruyne F.M., De La Rosette J.J., High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: Results of a prospective randomized study with year of fallowup, J. Urol., 158, 1, pp. 120-125, (1997)

[10]

Keoghane S.R., Lawrence K.C., Gray A.M., Chappel D.B., Hancock A.M., Cranston D.W., The Oxford laser prostate trial: Economic issues surrounding contact laser prostatectomy, Br. J. Urol., 77, 3, pp. 386-390, (1996)

← 1 →